Defective Cell Cycle Checkpoint Functions in Melanoma Are Associated with Altered Patterns of Gene Expression
Open accessThe DOI matches its Crossref record; 68 of the 70 references it cites were found in a registry or an index.
Abstract
Defects in DNA damage responses may underlie genetic instability and malignant progression in melanoma. Cultures of normal human melanocytes (NHMs) and melanoma lines were analyzed to determine whether global patterns of gene expression could predict the efficacy of DNA damage cell cycle checkpoints that arrest growth and suppress genetic instability. NHMs displayed effective G1 and G2 checkpoint responses to ionizing radiation-induced DNA damage. A majority of melanoma cell lines (11/16) displayed significant quantitative defects in one or both checkpoints. Melanomas with B-RAF mutations as a class displayed a significant defect in DNA damage G2 checkpoint function. In contrast the epithelial-like subtype of melanomas with wild-type N-RAS and B-RAF alleles displayed an effective G2 checkpoint but a significant defect in G1 checkpoint function. RNA expression profiling revealed that melanoma lines with defects in the DNA damage G1 checkpoint displayed reduced expression of p53 transcriptional targets, such as CDKN1A and DDB2, and enhanced expression of proliferation-associated genes, such as CDC7 and GEMININ. A Bayesian analysis tool was more accurate than significance analysis of microarrays for predicting checkpoint function using a leave-one-out method. The results suggest that defects in DNA damage checkpoints may be recognized in melanomas through analysis of gene expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While several studies found an association between DNA damage response gene upregulation and melanoma progression, the upregulated genes did not include NER genes64,65.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [64]
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Diagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R., Hastie, T., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,930
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836 · cited 2×
“Alterations in the p53 signaling pathway could contribute to melanoma genesis through attenuation of DNA repair, cell cycle checkpoint function, or apoptosis (Kastan and Bartek, 2004), leading to enhanced mutation and reduced cell death.”
BackgroundDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 6×
“Normal cell proliferation, as induced by growth factors in medium, did not cause DNA damage, suggesting that the disregulated S phase was responsible (Bartkova et al., 2005).”
BackgroundInfluentialMegabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo
Rogakou, E. P., Boon, C., Redon, C., & Bonner, W. M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.905 · Cited by 2,422
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 2×
“Expression of oncogenic B-RAF in normal melanocytes induces growth arrest through induction of p16 (Michaloglou et al., 2005; Gray-Schopfer et al., 2006).”
BackgroundActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 2×
“This condition of enhanced DNA damage and activation of the DNA damage response was induced in normal human fibroblasts by expression of gene products such as CDC6, cyclin E, and E2F1 that drive cells into a precocious S phase and by activated oncogenes, including H-RAS (Bartkova et al., 2005, 2006; Di Micco et al., 2…”
BackgroundOncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 1×
“…DNA damage and activation of the DNA damage response was induced in normal human fibroblasts by expression of gene products such as CDC6, cyclin E, and E2F1 that drive cells into a precocious S phase and by activated oncogenes, including H-RAS (Bartkova et al., 2005, 2006; Di Micco et al., 2006).”
Background
Cited by
Mechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
Roles of UVA radiation and DNA damage responses in melanoma pathogenesis
Khan, A. Q., Travers, J. B., & Kemp, M. G. (2018) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22176 · Cited by 152
“Inter- estingly, a majority of melanoma cell lines were found to display defects in one or both checkpoints following exposure to ionizing radiation [Kaufmann et al., 2008; Carson et al., 2012].”
BackgroundBonte, D., Lindvall, C., Liu, H., Dykema, K., Furge, K., & Weinreich, M. (2008) · Neoplasia · doi:10.1593/neo.08216 · Cited by 133
Scott, M. C., Sarver, A. L., Gavin, K. J., Thayanithy, V., Getzy, D. M., Newman, R. A., Cutter, G. R., Lindblad-Toh, K., Kisseberth, W. C., Hunter, L. E., et al. (2011) · Bone · doi:10.1016/j.bone.2011.05.008 · Cited by 121
Pal, H. C., Sharma, S., Strickland, L. R., Katiyar, S. K., Ballestas, M. E., Athar, M., Elmets, C. A., & Afaq, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086338 · Cited by 113
Skin Cancer: New Markers for Better Prevention
Greinert, R. (2009) · Pathobiology · doi:10.1159/000201675 · Cited by 86
DNA microarray analyses of melanoma gene expression: a decade in the mines
Hoek, K. S. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00412.x · Cited by 100
Pitchakarn, P., Suzuki, S., Ogawa, K., Pompimon, W., Takahashi, S., Asamoto, M., Limtrakul, P., & Shirai, T. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.041 · Cited by 83
EphA2 as a promoter of melanoma tumorigenicity
Margaryan, N. V., Strizzi, L., Abbott, D. E., Seftor, E. A., Rao, M. S., Hendrix, M. J. C., & Hess, A. R. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.3.7485 · Cited by 79
Składanowski, A., Bozko, P. M., & Sabisz, M. (2009) · Chemical Reviews · doi:10.1021/cr900026u · Cited by 77
Zebrafish Models of p53 Functions
Storer, N. Y., & Zon, L. I. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001123 · Cited by 76
ERBB3 is required for metastasis formation of melanoma cells
Tiwary, S., Preziosi, M., Rothberg, P. G., Zeitouni, N. C., Corson, N., & Xu, L. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.23 · Cited by 70
Cancer Biomarker Discovery: The Entropic Hallmark
Berretta, R., & Moscato, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012262 · Cited by 55
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
Gaddameedhi, S., Kemp, M. G., Reardon, J. T., Shields, J. M., Smith-Roe, S. L., Kaufmann, W. K., & Sancar, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0095 · Cited by 56
“Secondary cultures of NHMs were derived as reported previously (26).”
MethodSelf-citationMelanoma Biology and the Promise of Zebrafish
Ceol, C. J., Houvras, Y. J., White, R. M., & Zon, L. I. (2008) · Zebrafish · doi:10.1089/zeb.2008.0544 · Cited by 55
Nucleotide Excision Repair Gene Expression after Cisplatin Treatment in Melanoma
Bowden, N. A., Ashton, K. A., Avery‐Kiejda, K. A., Zhang, X. D., Hersey, P., & Scott, R. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0161 · Cited by 42
Zebrafish Models for Human Cancer
Shive, H. R. (2012) · Veterinary Pathology · doi:10.1177/0300985812467471 · Cited by 41
Chen, L., Zheng, S., Sun, Z., Wang, A., Huang, C., Punchard, N. A., Huang, S., Gao, X., & Lu, Y. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1440-8 · Cited by 40
Dominant Effects of Δ40p53 on p53 Function and Melanoma Cell Fate
Takahashi, R., Markovic, S. N., & Scrable, H. J. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.391 · Cited by 39
Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi
Clarke, L. E., Fountaine, T. J., Hennessy, J., Bruggeman, R. D., Clarke, J. T., Mauger, D. T., & Helm, K. F. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2008.01077.x · Cited by 37
Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells
Sarkar, S., Porter, K. I., Dakup, P., Gajula, R. P., Koritala, B. S. C., Hylton, R. K., Kemp, M. G., Wakamatsu, K., & Gaddameedhi, S. (2021) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12998 · Cited by 34
Mechanisms of chromosomal instability in melanoma
Kaufmann, W. K., Carson, C. C., Omolo, B., Filgo, A. J., Sambade, M. J., Simpson, D. A., Shields, J. M., Ibrahim, J. G., & Thomas, N. E. (2014) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21859 · Cited by 32
Self-citationRoss, A. D. M., Cook, M. G., Chong, H., Hossain, M., Pandha, H., & Bennett, D. C. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12060 · Cited by 31
Revised genetic requirements for the decatenation G2 checkpoint: The role of ATM
Bower, J. J., Zhou, Y., Zhou, T., Simpson, D. A., Arlander, S. J. H., Paules, R. S., Cordeiro‐Stone, M., & Kaufmann, W. K. (2010) · Cell Cycle · doi:10.4161/cc.9.8.11470 · Cited by 31
Self-citationZhou, L., YANG, K. Y., Wickett, R. R., Kadekaro, A. L., & Zhang, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-5293-6 · Cited by 31
DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma
Pavey, S. J., Spoerri, L., Haass, N. K., & Gabrielli, B. G. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12136 · Cited by 30
Millar, M. W., Corson, N., & Xu, L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00008 · Cited by 29
Song, Z., Lin, J., Sun, Z., Ni, J., & Yang, S. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.03.020 · Cited by 29
Biology of Melanocytes and Primary Melanoma
Zaidi, M. R., Fisher, D. E., & Rizos, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-05070-2_42 · Cited by 28
Anghel, S. I., Correa‐Rochal, R., Budínská, E., Boligan, K. F., Abraham, S., Colombetti, S., Fontao, L., Mariotti, A., Rimoldi, D., Ghanem, G., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.01018.x · Cited by 25
A prognostic signature of defective p53‐dependent G1 checkpoint function in melanoma cell lines
Carson, C. C., Omolo, B., Chu, H., Zhou, Y., Sambade, M. J., Peters, E. C., Tompkins, P., Simpson, D. A., Thomas, N. E., Fan, C., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.01010.x · Cited by 23
Self-citationSynthetic lethality: emerging targets and opportunities in melanoma
Thompson, N., Adams, D. J., & Ranzani, M. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12573 · Cited by 22
Sarasamma, S., Lai, Y., Liang, S., Liu, K., & Hsiao, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123929 · Cited by 21
Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapy
Viallard, C., Chezal, J., Mishellany, F., Ranchon‐Cole, I., Pereira, B., Herbette, A., Besse, S., Boudhraa, Z., Jacquemot, N., Cayre, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7340 · Cited by 20
A prognostic signature of G₂ checkpoint function in melanoma cell lines
Omolo, B., Carson, C. C., Chu, H., Zhou, Y., Simpson, D. A., Hesse, J. E., Paules, R. S., Nyhan, K. C., Ibrahim, J. G., & Kaufmann, W. K. (2013) · Cell Cycle · doi:10.4161/cc.24067 · Cited by 18
Self-citationDevelopment of DNA Damage Response Signaling Biomarkers using Automated, Quantitative Image Analysis
Nikolaishvilli-Feinberg, N., Cohen, S. M., Midkiff, B. R., Zhou, Y., Olorvida, M., Ibrahim, J. G., Omolo, B., Shields, J. M., Thomas, N. E., Groben, P. A., et al. (2013) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413516469 · Cited by 16
Self-citationKarwaciak, I., Gorzkiewicz, M., Ryba, K., Dastych, J., Pułaski, Ł., & Ratajewski, M. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.04.016 · Cited by 15
Nestin depletion induces melanoma matrix metalloproteinases and invasion
Lee, C., Zhan, Q., Lezcano, C. M., Frank, M. H., Huang, J. C., Larson, A. R., Lin, J. Y., Wan, M. T., Lin, P., Ma, J., et al. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.130 · Cited by 14
A Novel Role for RNF126 in the Promotion of G2 Arrest via Interaction With 14-3-3σ
Fa, P., Qiu, Z., Wang, Q., Yan, C., & Zhang, J. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.09.025 · Cited by 14
A predictive mathematical model of the DNA damage G2 checkpoint
Kesseler, K. J., Blinov, M. L., Elston, T. C., Kaufmann, W. K., & Simpson, D. A. (2012) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.12.011 · Cited by 12
Self-citationPrognostic Parameters for the Primary Care of Melanoma Patients: What Is Really Risky in Melanoma?
Göppner, D., & Leverkus, M. (2011) · Journal of Skin Cancer · doi:10.1155/2011/521947 · Cited by 11
Spoerri, L., Brooks, K. M., Chia, K., Grossman, G., Ellis, J. J., Dahmer‐Heath, M., Škalamera, D., Pavey, S. J., Burmeister, B. H., & Gabrielli, B. G. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12466 · Cited by 11
Bowden, N. A., Ashton, K. A., Vilain, R. E., Avery‐Kiejda, K. A., Davey, R. J., Murray, H. C., Budden, T., Braye, S. G., Zhang, X. D., Hersey, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070424 · Cited by 10
Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors
Winnepenninckx, V. J. L., & van den Oord, J. J. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.11.1611 · Cited by 9
DCARS: differential correlation across ranked samples
Ghazanfar, S., Strbenac, D., Ormerod, J. T., Yang, J. Y. H., & Patrick, E. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty698 · Cited by 8
Negreti, A. A., Ferreira‐Silva, G. Á., Pressete, C. G., Fonseca, R., Candido, C. C., Graminha, A. E., Doriguetto, A. C., Caixeta, E. S., Hanemann, J. A. C., Castro‐Gamero, A. M., et al. (2022) · New Journal of Chemistry · doi:10.1039/d1nj04291b · Cited by 8
PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells
George, A. L., Suriano, R., Rajoria, S., Osso, M. C., Tuli, N. Y., Hanly, E. K., Geliebter, J., Arnold, A. N., Wallack, M. K., & Tiwari, R. K. (2015) · Journal of Cancer · doi:10.7150/jca.11126 · Cited by 8
Biology of Melanocytes and Primary Melanoma
Zaidi, M. R., Fisher, D. E., & Rizos, H. (2018) · Springer eBooks · doi:10.1007/978-3-319-46029-1_42-1 · Cited by 7
Effective intra‐S checkpoint responses to UVC in primary human melanocytes and melanoma cell lines
Cordeiro‐Stone, M., McNulty, J. J., Sproul, C. D., Chastain, P. D., Gibbs-Flournoy, E. A., Zhou, Y., Carson, C. C., Rao, S., Mitchell, D. L., Simpson, D. A., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12426 · Cited by 6
Self-citationEvaluation of Methods for Gene Selection in Melanoma Cell Lines
Chaba, L., Odhiambo, J., & Omolo, B. (2016) · International Journal of Statistics in Medical Research · doi:10.6000/1929-6029.2017.06.01.1 · Cited by 6
Inhibition of Melanoma Cell Growth by Salvianolic Acid A through CHK2-CDC25A Pathway Modulation
Pu, X.-Y., Mei, Y., Zheng, Q., & Ko, C. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2906213 · Cited by 5
Sproul, C. D., Rao, S., Ibrahim, J. G., Kaufmann, W. K., & Cordeiro‐Stone, M. (2013) · Cell Cycle · doi:10.4161/cc.26590 · Cited by 4
Self-citationOncogenic BRAF(V600E) Induces Clastogenesis and UVB Hypersensitivity
Simpson, D. A., Lemonie, N., Morgan, D., Gaddameedhi, S., & Kaufmann, W. K. (2015) · Cancers · doi:10.3390/cancers7020825 · Cited by 3
Self-citationAvaliação de melanócitos humanos expostos ao inseticida carbaril e à radiação solar em cultura
Ferrucio, B. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2015.tde-28052015-085252 · Cited by 2
Deciphering the melanoma interactome
Reed, J. A. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2008.01119.x · Cited by 2
Downregulation of Cyclin Kinase Inhibitors p16 INK4a and p27 in Conjunctival Melanomas
Sarrasin, E., Lalys, E., Nardou, K., Çelik, E., Quinodoz, M., Schalenbourg, A., Riggi, N., Rivolta, C., Berger, A., & Moulin, A. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.1.59 · Cited by 1
A copula-based approach to differential gene expression analysis
Chaba, L., Omolo, B., & Odhiambo, J. (2006) · SU+ Digital Repository (Strathmore University) · Cited by 1
The Analysis of Novel Gene Targets in Breast Cancer in Women ≤35 years
Lambe, S. M. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Role of checkpoint kinase 1 in malignant melanoma
Smith, J. (2013) · Enlighten: Theses (The University of Glasgow)
Cisilotto, J. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Using Copulas to Select Prognostic Genes in Melanoma Patients
Chaba, L., Odhiambo, J., & Omolo, B. (2017) · International Journal of Statistics in Medical Research · doi:10.6000/1929-6029.2017.06.03.3
Der p53-Signalweg im Schleimhautmelanom
Metzler, V. M. (2017)
Tuning parameter selection in LASSO regression
Sottile, G., & Muggeo, V. M. R. (2016) · Nova Science Publishers (Nova Science Publishers, Inc.)
A Comparison of Parametric and Semi-Parametric Models for Microarray Data Analysis
Chaba, L., Odhiambo, J., & Omolo, B. (2017) · International Journal of Statistics in Medical Research · doi:10.6000/1929-6029.2017.06.04.1
Sproul, C. D. (2013) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/164p-y655
Análisis de la secreción de endoglina en exosomas y su relación con el proceso metastásico
Haro, S., & Peinado, H. (2015) · e_Buah
The role of the transcription factor BRN2 in melanoma
Herbert, K. J. (2018) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-mppdrnjz0
Data from Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
Gaddameedhi, S., Kemp, M. G., Reardon, J. T., Shields, J. M., Smith‐Roe, S. L., Kaufmann, W. K., & Sancar, A. (2023) · doi:10.1158/0008-5472.c.6500036.v1
Self-citationViallard, C. (2015) · theses.fr (ABES) · doi:10.70675/492c81dbzd67dz4472z9dc2z0a9c6202a1a2
Skin cancer: Biomarker landscape
Chauhan, N., Moin, A., Yadav, V. K., Gupta, M., Sen, P., & Saini, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33902-8.00011-0
Radiothérapie interne du mélanome métastatique pigmenté : mécanismes et associations
Rouanet, J. (2019) · theses.fr (ABES) · doi:10.70675/c28349fdz1635z480bzb4e7za5f431ee26c8
DDERMMAL, a melanocytic long non-coding RNA, confers DNA damage tolerance to melanoma cells
Adnane, S., Verheyden, Y., Cuomo, A., Bonaldi, T., & Leucci, E. (2026) · iScience · doi:10.1016/j.isci.2026.116251
Metadata
- Authors
- Kaufmann, W. K., Nevis, K. R., Qu, P., Ibrahim, J. G., Zhou, T., Zhou, Y., Simpson, D. A., Helms-Deaton, J., Cordeiro-Stone, M., Moore, D. T., Thomas, N. E., Hao, H., Liu, Z., Shields, J. M., Scott, G. A., & Sharpless, N. E.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- University of Rochester Medicine (US)
- Corresponding author
- Kaufmann, William K.
- ORCID
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 128
- Issue
- 1
- Pages
- 175-187
- ISSN
- 0022-202X (ISSN-L)
- PMC
- PMC2753794
- OpenAlex
- W1981058260
- Cited by
- 65
- References
- 70
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 5 · 2013: 7 · 2012: 5
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2892 d)
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Cancer Institute (CA-160-86, R01CA112243, T32CA106209, P30CA016086)
- National Institute of General Medical Sciences (R01GM070335)
- National Institute of Environmental Health Sciences (ES07017, U19ES011391, ES-11391, ES 10126, T32ES007017, P30ES010126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- melanoma, DNA damage response, cell cycle checkpoints, G1/S checkpoint, G2 checkpoint, genomic instability, BRAF mutation, NRAS, p21, DDB2, CDC7, geminin, gene expression profiling, ionizing radiation, melanocytes, Bayesian analysis, significance analysis of microarrays
- MeSH terms
- Cells, Cultured, DNA Damage, DNA-Binding Proteins, Humans, Melanocytes, Melanoma, Mutation, Phosphorylation, Tumor Suppressor Protein p53, G1 Phase, G2 Phase, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Gene Expression Profiling, Chromosomal Instability, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, Cyclin-Dependent Kinase Inhibitor p21, DNA Breaks, Double-Stranded, Geminin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.